17-Beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease

Flavio Airoldi; Carlo Di Mario; Flavio Ribichini; Patrizia Presbitero; Paolo Sganzerla; Valeria Ferrero; Corrado Vassanelli; Carlo Briguori; Mauro Carlino; Matteo Montorfano; Giuseppe G L Biondi-Zoccai; Alaide Chieffo; Angela Ferrari; Antonio Colombo

doi:10.1016/j.amjcard.2005.04.040

17-Beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease

Flavio Airoldi, Carlo Di Mario, Flavio Ribichini, Patrizia Presbitero, Paolo Sganzerla, Valeria Ferrero, Corrado Vassanelli, Carlo Briguori, Mauro Carlino, Matteo Montorfano, Giuseppe G L Biondi-Zoccai, Alaide Chieffo, Angela Ferrari, Antonio Colombo

Research output: Contribution to journal › Article › peer-review

Abstract

In this study we randomly compared the estradiol eluting stent (17-β-E) with phosphorylcholine (PC)-coated stents in native coronary arteries. The incidence of angiographic restenosis was 23% in the 17-β-E group and 31% in the PC group (p = 0.34). The major adverse cardiovascular event rates were also similar in the 2 groups (17% in the 17-β-E group vs 22% in the PC group, p = 0.47). The mid-term clinical and angiographic outcomes did not indicate superiority of the 17-β-E eluting stent over the control PC stent.

Original language	English
Pages (from-to)	664-667
Number of pages	4
Journal	The American Journal of Cardiology
Volume	96
Issue number	5
DOIs	https://doi.org/10.1016/j.amjcard.2005.04.040
Publication status	Published - Sep 1 2005

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.amjcard.2005.04.040

Fingerprint Dive into the research topics of '17-Beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease'. Together they form a unique fingerprint.

Cite this

Airoldi, F., Di Mario, C., Ribichini, F., Presbitero, P., Sganzerla, P., Ferrero, V., Vassanelli, C., Briguori, C., Carlino, M., Montorfano, M., Biondi-Zoccai, G. G. L., Chieffo, A., Ferrari, A., & Colombo, A. (2005). 17-Beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease. The American Journal of Cardiology, 96(5), 664-667. https://doi.org/10.1016/j.amjcard.2005.04.040

17-Beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease. / Airoldi, Flavio; Di Mario, Carlo; Ribichini, Flavio; Presbitero, Patrizia; Sganzerla, Paolo; Ferrero, Valeria; Vassanelli, Corrado; Briguori, Carlo; Carlino, Mauro ; Montorfano, Matteo; Biondi-Zoccai, Giuseppe G L; Chieffo, Alaide; Ferrari, Angela; Colombo, Antonio.

In: The American Journal of Cardiology, Vol. 96, No. 5, 01.09.2005, p. 664-667.

Research output: Contribution to journal › Article › peer-review

Airoldi, F, Di Mario, C, Ribichini, F, Presbitero, P, Sganzerla, P, Ferrero, V, Vassanelli, C, Briguori, C, Carlino, M , Montorfano, M, Biondi-Zoccai, GGL, Chieffo, A, Ferrari, A & Colombo, A 2005, '17-Beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease', The American Journal of Cardiology, vol. 96, no. 5, pp. 664-667. https://doi.org/10.1016/j.amjcard.2005.04.040

Airoldi, Flavio ; Di Mario, Carlo ; Ribichini, Flavio ; Presbitero, Patrizia ; Sganzerla, Paolo ; Ferrero, Valeria ; Vassanelli, Corrado ; Briguori, Carlo ; Carlino, Mauro ; Montorfano, Matteo ; Biondi-Zoccai, Giuseppe G L ; Chieffo, Alaide ; Ferrari, Angela ; Colombo, Antonio. / 17-Beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease. In: The American Journal of Cardiology. 2005 ; Vol. 96, No. 5. pp. 664-667.

@article{a43761e6fda14edbacef822f47818f9e,

title = "17-Beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease",

abstract = "In this study we randomly compared the estradiol eluting stent (17-β-E) with phosphorylcholine (PC)-coated stents in native coronary arteries. The incidence of angiographic restenosis was 23% in the 17-β-E group and 31% in the PC group (p = 0.34). The major adverse cardiovascular event rates were also similar in the 2 groups (17% in the 17-β-E group vs 22% in the PC group, p = 0.47). The mid-term clinical and angiographic outcomes did not indicate superiority of the 17-β-E eluting stent over the control PC stent.",

author = "Flavio Airoldi and {Di Mario}, Carlo and Flavio Ribichini and Patrizia Presbitero and Paolo Sganzerla and Valeria Ferrero and Corrado Vassanelli and Carlo Briguori and Mauro Carlino and Matteo Montorfano and Biondi-Zoccai, {Giuseppe G L} and Alaide Chieffo and Angela Ferrari and Antonio Colombo",

year = "2005",

month = sep,

day = "1",

doi = "10.1016/j.amjcard.2005.04.040",

language = "English",

volume = "96",

pages = "664--667",

journal = "American Journal of Cardiology",

issn = "0002-9149",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - 17-Beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease

AU - Airoldi, Flavio

AU - Di Mario, Carlo

AU - Ribichini, Flavio

AU - Presbitero, Patrizia

AU - Sganzerla, Paolo

AU - Ferrero, Valeria

AU - Vassanelli, Corrado

AU - Briguori, Carlo

AU - Carlino, Mauro

AU - Montorfano, Matteo

AU - Biondi-Zoccai, Giuseppe G L

AU - Chieffo, Alaide

AU - Ferrari, Angela

AU - Colombo, Antonio

PY - 2005/9/1

Y1 - 2005/9/1

N2 - In this study we randomly compared the estradiol eluting stent (17-β-E) with phosphorylcholine (PC)-coated stents in native coronary arteries. The incidence of angiographic restenosis was 23% in the 17-β-E group and 31% in the PC group (p = 0.34). The major adverse cardiovascular event rates were also similar in the 2 groups (17% in the 17-β-E group vs 22% in the PC group, p = 0.47). The mid-term clinical and angiographic outcomes did not indicate superiority of the 17-β-E eluting stent over the control PC stent.

AB - In this study we randomly compared the estradiol eluting stent (17-β-E) with phosphorylcholine (PC)-coated stents in native coronary arteries. The incidence of angiographic restenosis was 23% in the 17-β-E group and 31% in the PC group (p = 0.34). The major adverse cardiovascular event rates were also similar in the 2 groups (17% in the 17-β-E group vs 22% in the PC group, p = 0.47). The mid-term clinical and angiographic outcomes did not indicate superiority of the 17-β-E eluting stent over the control PC stent.

UR - http://www.scopus.com/inward/record.url?scp=23944463886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23944463886&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2005.04.040

DO - 10.1016/j.amjcard.2005.04.040

M3 - Article

C2 - 16125491

AN - SCOPUS:23944463886

VL - 96

SP - 664

EP - 667

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 5

ER -